Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority claimed from PCT/US2009/059458external-prioritypatent/WO2010040113A1/en
Publication of UA108838C2publicationCriticalpatent/UA108838C2/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Abstract
Винахід стосується застосування складу з уповільненим і пролонгованим вивільненням у вигляді чотирьох капсул з желатиновою оболонкою, кожна з яких містить гранульованого мезаламіну, один раз на добу зранку незалежно від приймання їжі, для підтримки ремісії виразкового коліту.The invention relates to the use of a delayed and sustained release formulation in the form of four capsules with gelatin shell, each containing granulated mesalamine, once a day in the morning regardless of food intake, to support ulcerative colitis remission.
UAA201105445A2008-10-032009-02-10
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF THE GUT WITH THE USE OF PULLED MESALAMINE
UA108838C2
(en)
DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PRODUCTION
Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids.